Hypoxia-induced YTH-domain family 2 (YTHDF2) is reported to inhibit hepatocellular carcinoma (HCC) growth via destabilizing EGFR mRNA, which may contribute to resistance to tumorigenesis in a hypoxic environment [34]. This evidence concerns the gene YTHDF2 and hepatocellular carcinoma.